Furthermore, mechanistic studies suggest that KCZ and KCZ-7 inhibit tGLI1-positive breast cancer by reducing tGLI1 DNA binding, leading to reduced promoter occupancy and promoter transactivation and the downregulation of the tGLI1-mediated stemness genes Nanog and OCT4. The gene discussed is NANOG; the disease is breast cancer.